Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/COYA/Revenue

Coya Therapeutics, Inc. (COYA) Revenue 2022–2025

Coya Therapeutics, Inc. (COYA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$7.9MFY2025 · since FY2022: $0 → $7.9M
22232425
Fiscal yearValueYoY
FY2025$7.9M+123.6%
FY2024$3.6M-40.8%
FY2023$6.0M—
FY2022$0—

Source: SEC XBRL filings · For reference only · Not investment advice

More COYA financial trends

COYA Net incomeCOYA Net marginCOYA Gross profitCOYA Gross marginCOYA Operating incomeCOYA Operating marginCOYA Operating cash flowCOYA Free cash flowCOYA Capital expendituresCOYA Return on equityCOYA Stock buybacksCOYA Dividends paidCOYA Total assetsCOYA Total liabilitiesCOYA Shareholders’ equityCOYA overview →